LONDON (Reuters) – Two doses of the Oxford/AstraZeneca COVID-19 vaccine is around 85% to 90% effective against symptomatic disease, Public Health England (PHE) said on Thursday, citing an analysis of real-world data from the rollout of the shot.
PHE also estimated that the COVID-19 vaccine programme overall had prevented the deaths of 13,000 over-60s up to May 9, and stopped 39,100 of those over 65 from needing hospital treatment from COVID-19.
(Reporting by Alistair Smout; Editing by Kate Holton)
